Vaccination

Pfizer vaccine moves closer to getting the OK in the US

U.S. regulators Tuesday released their first scientific evaluation of Pfizer's COVID-19 vaccine and confirmed it offers strong protection, setting the stage for the government to green light the biggest vaccination effort ...

Medical research

Has quality suffered in the rush to publish COVID-19 research?

Rapid dissemination of information should not come at the expense of quality, ethical standards or oversight, according to the authors of a Perspective published online today by the Medical Journal of Australia.

Diseases, Conditions, Syndromes

WHO advises against remdesivir for coronavirus treatment

The anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has "no important effect" on survival chances, the World Health Organization said Friday.

Diseases, Conditions, Syndromes

Lancet blasts Trump's virus 'disaster', urges vote for change

The Lancet has become the latest science journal to urge Americans to vote for change in next week's presidential election, publishing a scathing editorial Friday that described the US pandemic response under Donald Trump ...

Diseases, Conditions, Syndromes

Taiwan marks 200 days without domestic COVID-19 infection

Taiwan hit 200 days without any domestically transmitted cases of COVID-19 on Thursday, highlighting the island's continued success at keeping the virus under control even as cases surge in other parts of the world.

page 16 from 40